Pharmacokinetics and safety of JTE-522, a novel selective cyclooxygenase-2 inhibitor, in healthy male volunteers

AIMS: The pharmacokinetics and safety profile of JTE-522, 4-(4-cyclohexyl-2 methyloxazol-5-yl)-2-fluorobenzensulphonamide, a novel selective cyclooxygenase-2 inhibitor were investigated in healthy male volunteers. METHODS: Initially, as a pilot study, five groups of two subjects were given oral dose...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ikeda, Yasuhiko, Umemura, Kazuo, Kondo, Kazunao, Nakashima, Mitsuyoshi, Kobayashi, Takuo, Takahashi, Mitsuru
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Science Inc 2002
Assuntos:
Pharmacokinetics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1874460/
https://ncbi.nlm.nih.gov/pubmed/12445023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2002.01676.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares